Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Recruiting 3Completed 3Unknown 1Active not recruiting 1

Sponsor Class

OTHER 73OTHER_GOV 6INDUSTRY 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1

Interventions

Paclitaxel 490Carboplatin 436Gemcitabine 394Docetaxel 385Cisplatin 360pembrolizumab 344Bevacizumab 335Nivolumab 261Pemetrexed 243Capecitabine 221Dexamethasone 213Fluorouracil 211Rituximab 203Trastuzumab 193Cyclophosphamide 190Oxaliplatin 160Erlotinib Hydrochloride 147Ipilimumab 145atezolizumab 144Prednisone 144Cetuximab 142Irinotecan 139Leucovorin 130Doxorubicin 130Sorafenib 120Lenalidomide 119Bortezomib 118Sunitinib 107Everolimus 93130-nm albumin-bound paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Control Groups × Clear all
NCT06317103 2024-03-19

A Clinical Trial to Evaluate the Sensitivity and Specificity of "WAYMED Endo" Compared to the Endoscopists in Classifying Early Gastric Cancer (EGC) Based on the Depth of Invasion in Endoscopic Images

WAYCEN Inc

Completed
653 enrolled
Gastrointestinal

Stomach Neoplasms

NCT05301556 2024-03-01

Food for Special Medical Purpose in Patients With Digestive Tract Tumor

Abbott Nutrition

Phase NA Completed
326 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT02870582 2022-11-29

Donafenib for Previously Treated Metastatic Colorectal Cancer

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Phase 3 Completed
536 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡